DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China
· Delayed Price · Currency is CNY 19.45
-0.37 (-1.87%)
At close: Mar 9, 2026
SHA:603233 Revenue
DaShenLin Pharmaceutical Group had revenue of 6.55B CNY in the quarter ending September 30, 2025, with 2.51% growth. This brings the company's revenue in the last twelve months to 26.83B, up 1.11% year-over-year. In the year 2024, DaShenLin Pharmaceutical Group had annual revenue of 26.50B with 8.01% growth.
Revenue (ttm)
26.83B
Revenue Growth
+1.11%
P/S Ratio
0.83
Revenue / Employee
616.42K
Employees
43,532
Market Cap
22.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.50B | 1.97B | 8.01% |
| Dec 31, 2023 | 24.53B | 3.28B | 15.45% |
| Dec 31, 2022 | 21.25B | 4.49B | 26.78% |
| Dec 31, 2021 | 16.76B | 2.18B | 14.92% |
| Dec 31, 2020 | 14.58B | 3.44B | 30.89% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yifeng Pharmacy Chain | 24.13B |
| LBX Pharmacy Chain Joint Stock Company | 22.20B |
| Anhui Huaren Health Pharmaceutical | 5.15B |
| Yixintang Pharmaceutical Group | 17.41B |
| ShuYu Civilian Pharmacy Corp. | 9.94B |
| Luyan Pharma | 20.91B |
| Cachet Pharmaceutical | 19.99B |
| Sichuan Hezong Medicine Easy-to-buy Pharmaceutical | 4.39B |